69 Deep Tech Startups in UK to Watch in 2024
How do we build this list?
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Antibody-Drug Conjugate specialist creating treatments for tough-to-treat cancers. |
$120M · Series B | TCG Crossover, Atlas Ventures, Brandon Capital | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma | B2B | London, UK | •••••••••••@pheontx.com | |
Digital assets central clearing paltform. |
$10M · Seed | GSR, Zodia Custody, LMAX Digital | 1 to 10 | Fintech, Deep Tech | B2B, SaaS | London, UK | •••••••••••@cleartoken.io | |
Ethereum-based token streaming platform. |
$5M · Seed | Multicoin Capital, Circle Ventures, Safe | 11 to 50 | Fintech, Deep Tech | B2B, SaaS | London, UK | •••••••••••@superfluid.finance | |
On-chain asset management infrastructure provider. |
$1M · Pre Seed | 8VC, Mako Trading, Marshland Group | 11 to 50 | Crypto & web3, Deep Tech | B2B, SaaS | London, UK | •••••••••••@quantamm.fi | |
Platform specializing in developing new, high-yield tropical crop varieties and traits. |
$28M · Series B | Future Planet Capital | 11 to 50 | Agritech, Biotech, Deep Tech, Manufacturing | B2B | London, UK | •••••••••••@tropicbioscience.com | |
Decentralised trading platform. |
$2M · Pre Seed | Speedinvest, Keyrock, Daedalus Angel Syndicate | 11 to 50 | Deep Tech, Investing | B2B, SaaS | London, UK | •••••••••••@rho.trading | |
Protein discovery research and manufacturing. |
$19M · Series A | SYSTEMIQ | 11 to 50 | Biotech, Deep Tech | London, UK | •••••••••••@basecamp-research.com | ||
Silicon-oxide based RRAM technologies. |
$8M · Series A | Octopus Ventures | 1 to 10 | Deep Tech, Semiconductor | London, UK | •••••••••••@intrinsicsemi.com | ||
OS for electricity grids. |
$10M · Series B | Clean Growth Fund, Future Energy Ventures | 11 to 50 | Climate Tech & Green Tech, Deep Tech, Energy & Nuclear | B2B, Marketplace | London, UK | •••••••••••@piclo.energy | |
3D human lung model developer. |
$2M · Seed | Pioneer Group, Mercia Asset Management, Midlands Engine Investment Fund | 11 to 50 | Biotech, Deep Tech | London, UK | •••••••••••@immuone.com | ||
Large language model (LLM) data insights platform. |
$1M · Pre Seed | 500 Emerging Europe, Episode 1 | 1 to 10 | Deep Tech | B2B, SaaS | London, UK | •••••••••••@getsentify.ai | |
Generative engineering platform for physical products. |
$4M · Pre Seed | EQT Ventures, Join Capital | 11 to 50 | Deep Tech, Manufacturing | B2B, SaaS | London, UK | •••••••••••@generative.vision | |
Robotic kitchen automation transforms Quick Service and Fast Casual restaurants. |
$8M · Seed | Hoxton Ventures, Firstminute Capital | 11 to 50 | Foodtech, Deep Tech, Machine Learning, Robotics, Manufacturing | B2B | London, UK | •••••••••••@karakuri.com | |
Platform that improves how humans and machines understand and interact with each other. |
$5M · Seed | Anthemis | 11 to 50 | AI, Deep Tech, Proptech & Real Estate, Machine Learning, Music and Audio, Data and Analytics, Mobility & Transportation | B2B | London, UK | •••••••••••@humanisingautonomy.com | |
Intelligent test automation. |
$6M · Series A | YFM Equity Partners | 11 to 50 | Deep Tech | London, UK | •••••••••••@automatepro.com | ||
Health and quality inspection platform. |
$5M · Series A | octopus investments | 11 to 50 | Health Tech, Deep Tech, Robotics, Manufacturing | B2B, SaaS | London, UK | •••••••••••@perfectward.com | |
Platform capturing real-time insights of warehouse operations using fully autonomous robots and Artificial Intelligence. |
$6M | Kindred Capital, Lakestar, Capnamic Ventures | 11 to 50 | AI, Deep Tech, Data and Analytics, Robotics, Manufacturing, Ecommerce | B2C, SaaS | London, UK | •••••••••••@botsandus.com | |
Drug discovery platform focused on developing small molecule inhibitors. |
$6M · Seed | Sofinnova Partners | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | London, UK | •••••••••••@myricxpharma.com | |
AI-powered optimization engine that helps businesses scale and automate logistics and supply chains. |
$3M · Seed | Local Globe, Crane Venture Partners, Eight Roads Ventures | 11 to 50 | AI, Deep Tech, Data and Analytics | B2B, SaaS | London, UK | •••••••••••@the7bridges.com | |
Biopharmaceutical company developing protein therapeutics with a machine learning-driven evolution engine. |
$3M · Seed | Atomico, Kindred Capital, Felicis Ventures | 51 to 100 | Health Tech, AI, Biotech, Deep Tech, Machine Learning, Robotics, Manufacturing | B2B | London, UK | •••••••••••@labgeni.us | |
Software for robots and autonomous machines to understand and navigate their environment. |
$5M | Octopus Ventures, MMC Ventures, Amadeus Capital | 11 to 50 | AI, AR / VR, Deep Tech, Drones, Data and Analytics, Robotics, Manufacturing | B2B, SaaS | London, UK | •••••••••••@slamcore.com | |
Ordinals infrastructure paltform for developers. |
$1M · Seed | Kestrel 0x1, Lightning Ventures, Bitcoin Frontier Fund | 1 to 10 | Crypto & web3, Deep Tech | B2B | London, UK | •••••••••••@ordinalsbot.com | |
Platform offering advanced solutions for efficient semiconductor manufacturing. |
$3M · Seed | BACKED VC, Entrepreneur First, Join Capital | 11 to 50 | AI, Deep Tech, Machine Learning, Manufacturing, Semiconductor | B2B | London, UK | •••••••••••@flexciton.com | |
Immuno-oncology company treats cancer with antibodies. |
$2M · Series A | AlbionVC, Novartis Venture Fund, Epidarex Capital | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Genetics | B2B | London, UK | •••••••••••@epsilogen.com | |
Platform providing organizations with advanced data analytics tools. |
$4M | AlbionVC, Finch Capital, Amadeus Capital | 11 to 50 | Hardware, Deep Tech, Data and Analytics, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@brytlyt.com | |
Platform helping the food sector reduce its carbon footprint. |
$4M | Octopus Ventures, Ascension Ventures, Metaplanet Holdings | 11 to 50 | Climate Tech & Green Tech, Health Tech, Agritech, Foodtech, Biotech, Deep Tech, Energy & Nuclear, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@foodsteps.earth | |
Platform for developing materials that precisely target and remove harmful chemicals like PFAS from water. |
$3M · Seed | Kindred Capital, Verve Ventures | 11 to 50 | Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Manufacturing | B2B | London, UK | •••••••••••@puraffinity.com | |
Blockchain infrastructure and tooling platform. |
$2M · Seed | Klaytn, NexusOne, Gate.io | 11 to 50 | Crypto & web3, Deep Tech | B2B, SaaS | London, UK | •••••••••••@kanalabs.io | |
Platform offering personalized digital health solutions for chronic gynecological conditions like endometriosis and PCOS. |
$253k · Seed | Y Combinator, Katapult Accelerator | 1 to 10 | Health Tech, Biotech, Deep Tech, Femtech, Ecommerce, ElderTech, Fertility | B2B | London, UK | •••••••••••@syronahealth.com | |
Synthetic data cloud platform. |
$290k · Pre Seed | Edge VC, High-Tech Gründerfonds, Cogito Capital Partners | 11 to 50 | Deep Tech, Data and Analytics | B2B, SaaS | London, UK | •••••••••••@skyengine.ai | |
One lab management platform that brings people, equipment and data together - no matter where they are. |
$1M | Forward Partners | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B, SaaS | London, UK | •••••••••••@clustermarket.com | |
Decentralised AI training and finetuning platform. |
$2M · Pre Seed | Lightspeed Faction, Tagus Capital | 1 to 10 | AI, Deep Tech | B2B, SaaS | London, UK | •••••••••••@flock.io | |
Platform providing same-day, tailored life insurance for individuals with chronic conditions such as type 2 diabetes and heart diseases. |
$1M · Seed | Insurtech Gateway, Portfolio Ventures | 1 to 10 | Health Tech, Fintech, Biotech, Deep Tech, Insuretech | B2C | London, UK | •••••••••••@bluezoneinsurance.co.uk | |
Biotechnology platform accelerating cancer cell therapy discoveries with AI-driven TCR-antigen screening. |
$104k · Pre Seed | Atomico, Entrepreneur First | 1 to 10 | Health Tech, AI, Biotech, Deep Tech, Pharma, Data and Analytics | B2B | London, UK | •••••••••••@exogene.co.uk | |
Platform offering advanced targeted RNA, DNA, and CRISPR therapies. |
$125k · Pre Seed | Y Combinator | 1 to 10 | Health Tech, Biotech, Deep Tech | B2B | London, UK | •••••••••••@nuntiustx.com | |
Platform for improving brain health. |
$450k · Pre Seed | Octopus Ventures, Calm/Storm Ventures | 11 to 50 | Health Tech, Hardware, Deep Tech, Mobile, Business Intelligence | B2B, B2C | London, UK | •••••••••••@letsmindstep.com | |
Transforming mental healthcare by unlocking the power of clinical data |
$52M · Series B | Molten Ventures | 101 to 250 | Health Tech, Deep Tech | B2B, B2C | Cambridge, UK | •••••••••••@iesogroup.com | |
Super-resolution microscopy platform that makes advanced imaging technology accessible to researchers. |
$75M · Series B | Axon Ventures, Oxford Science Enterprises | 51 to 100 | Health Tech, Biotech, Deep Tech, Robotics, Manufacturing, Developer Tools | B2B | Oxford, UK | •••••••••••@oni.bio | |
Lab-quality diagnostics for anyone, anywhere, at any time. |
$85M | Oxford Science Enterprises | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Oxford, UK | •••••••••••@oslerdiagnostics.com | |
Software for autonomous vehicles. |
$140M · Series C | Kiko Ventures, Business Growth Fund | 251 to 500 | AI, Deep Tech, Machine Learning, Music and Audio, Mobility & Transportation | B2B, SaaS | Oxford, UK | •••••••••••@oxbotica.ai | |
Developer and manufacturer of zero-emission public transportation vehicles. |
$111M · Series A | 1001 to 5000 | Climate Tech & Green Tech, Hardware, Deep Tech, Music and Audio, Mobility & Transportation, Manufacturing, Electric Vehicles | B2B | London, UK | •••••••••••@arrival.com | ||
Platform focused on utilizing the body's natural immune control mechanisms. |
$97M · Series B | Medicxi, Oxford Science Enterprises | 1 to 10 | Health Tech, Biotech, Deep Tech | B2B | Oxford, UK | •••••••••••@mirobio.com | |
Platform for advancing neuroscience and neurophysiology solutions. |
$2M · Seed | IQ Capital Partners, Techstart Ventures | 1 to 10 | Health Tech, Hardware, Biotech, Deep Tech, Manufacturing, Wearables | B2B | Belfast, UK | •••••••••••@neurovalens.com | |
Human microbiome therapeutics developer creating live bacterial treatments and biomarkers. |
$66M | Seventure Partners, Cambridge Innovation Capital | 11 to 50 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@microbiotica.com | |
Immunotherapy for bladder cancer. |
$30M · Series B | 11 to 50 | Health Tech, Biotech, Deep Tech | London, UK | •••••••••••@prokarium.com | |||
Platform for automating life sciences experiments and integrating the resulting data. |
N/A | Sofinnova Partners | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Internet of Things | B2B, SaaS | London, UK | •••••••••••@synthace.com | |
Neural technology company developing advanced noninvasive neural interfaces. |
N/A | Entrepreneur First | 1 to 10 | Health Tech, Hardware, AI, Deep Tech, Machine Learning, Data and Analytics, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@comind.io | |
Platform that makes rehabilitation more autonomous, enjoyable, and accessible for stroke victims. |
N/A | AlbionVC, InHealth Ventures | 1 to 10 | Health Tech, Hardware, Deep Tech, Music and Audio, Mobility & Transportation, Manufacturing, Service Industry | B2B | London, UK | •••••••••••@neurofenix.com | |
Trading name of Seyo Limited, a company in England and Wales. |
N/A | Entrepreneur First, 7percent Ventures, Ascension Ventures | 1 to 10 | Deep Tech, Robotics, Manufacturing | B2B, SaaS | London, UK | •••••••••••@seyo.io | |
Biotechnology company focused on developing therapeutic medicines by harnessing gene activation mechanisms. |
$29M | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma, Genetics | B2B | London, UK | •••••••••••@minatx.com | ||
Desktop technology making biology accessible by synthesizing proteins and genes. |
$42M · Series B | Future Planet Capital, Amadeus Capital, Verve Ventures | 11 to 50 | Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@nuclera.com | |
"Biotechnology platform producing sugar substitutes." |
$24M | Khosla Ventures, Felicis Ventures, Y Combinator | 11 to 50 | Health Tech, Foodtech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@supplant.com | |
Startup developing technology that helps nature break down plastic pollution. |
$18M | 11 to 50 | Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Manufacturing | B2B | London, UK | •••••••••••@polymateria.com | ||
Platform that simulates real-world scenarios in real time to help computers solve practical problems. |
$10M | 51 to 100 | Deep Tech, Data and Analytics, Privacy and Security, Manufacturing | B2B, SaaS | London, UK | •••••••••••@sensat.co.uk | ||
Manufacturer of deployable antennas for spacecraft. |
$3M · Seed | UK Innovation & Science Seed Fund | 11 to 50 | Deep Tech, Space Tech | Oxford, UK | •••••••••••@oxford.space | ||
Platform for understanding and defining the biological codes that make up human cells. |
$41M · Series A | Metaplanet Holdings, BlueYard Capital | 101 to 250 | Health Tech, Biotech, Deep Tech, Business Intelligence | B2B | Cambridge, UK | •••••••••••@bit.bio | |
Platform enabling the development of cell therapies through advanced reprogramming techniques. |
$10M · Series A | Astellas Venture Management, Parkwalk Advisors, Ahren Innovation Capital | 101 to 250 | Health Tech, Biotech, Deep Tech | B2B | Cambridge, UK | •••••••••••@mogrify.co.uk | |
Contract Research Organization specializing in bioscience research services. |
$4M · Series A | Gresham House Ventures, NPIF Maven Equity Finance | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@metrionbiosciences.com | ||
Enterprise-grade SaaS product offering blockchain solutions adaptable to various platforms. |
$3M | 11 to 50 | Fintech, Crypto & web3, Deep Tech, Media and Entertainement, Manufacturing, Supply Chain & Logistics | B2B, SaaS | London, UK | •••••••••••@finboot.com | ||
Biotechnology company dedicated to the prevention, detection, and diagnosis of viral diseases. |
$3M | 11 to 50 | Health Tech, Deep Tech | London, UK | •••••••••••@viraxbiolabs.com | |||
Software for advanced sourcing optimization and intelligent sourcing automation. |
$18M · Series A | 83North, Mosaic Ventures, Paua Ventures | 101 to 250 | Deep Tech, Robotics, Manufacturing, Supply Chain & Logistics, IT Management | B2B, SaaS | Cork, UK | •••••••••••@keelvar.com | |
Cancer diagnostics. |
$16M · Series A | Business Growth Fund | 51 to 100 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@cyted.ai | ||
Pet therapeutics startup dedicated to developing medicines for pets. |
$13M · Series A | Cambridge Innovation Capital, Parkwalk Advisors | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@petmedix.co.uk | |
Supplier of configurable process node agnostic analog IP building blocks. |
$5M · Seed | Omers Ventures, Firstminute Capital, MMC Ventures | 11 to 50 | Deep Tech, Manufacturing, Semiconductor | B2B | Cambridge, UK | •••••••••••@agileanalog.com | |
Manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications. |
$5M · Series B | Parkwalk Advisors, Downing Ventures | 11 to 50 | Biotech, Deep Tech | Cambridge, UK | •••••••••••@qkine.com | ||
Platform offering biomedical research services. |
$7M | Triple Point Ventures | 11 to 50 | Health Tech, Biotech, Deep Tech, Data and Analytics | Manchester, UK | •••••••••••@biorelate.com | ||
Cancer immunotherapeutics company working across the Atlantic. |
$13M · Seed | Cambridge Innovation Capital | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@epitopea.com | |
Fibroblast technology designed to develop new therapies for diseases. |
$11M · Seed | GV, Forbion Capital Partners | 1 to 10 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@mestagtx.com | |
A synthetic antibody company based in East Midlands, UK. |
$6M | Calculus Capital, Business Growth Fund | 1 to 10 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B, B2C, SaaS | Leicester, UK | •••••••••••@mip-dx.com |
Sign up to access our full database
Enter your email and get access to 18,000+ technology companies you can partner with.